Stock Quote
Genomic Health, Inc. (GHDX.W) (NASD ADF)
$19.75
12 Nov 2009
-1.59%
$20.07
$19.75
1,000
$19.75
$19.75
$27.22
$15.81
0.68
135,329
GHDX.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Scott, Randal | Executive Chairman of the Board | 697,800 |
| Popovits, Kimberly | President, Chief Executive Officer, Director | 803,450 |
| Cole, G. Bradley | Chief Financial Officer, Chief Operating Officer, Secretary | 761,700 |
Profile
Genomic Health, Inc. (Genomic Health) is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. The Company’s diagnostic test, Oncotype DX, is used... Full Description
Company Address
Genomic Health, Inc.
301 Penobscot Drive
Redwood City CA 94063
P: +1650.5569300
F: +1650.5561132
301 Penobscot Drive
Redwood City CA 94063
P: +1650.5569300
F: +1650.5561132
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Celera Corporation | $6.31 | +0.06 |
| Clarient, Inc. | $2.54 | +0.07 |
| Genzyme Corporation | $50.48 | +0.43 |
| GHDX.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 3.91 | 29.90 |
| ROI(TTM) | -16.72 | 2.35 |
| ROE(TTM) | -17.39 | 3.59 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | -0.02 |
| EPS Est. (Current Year) | -0.36 |
| Total Revenue | $39.52M |
| Net Income | $-0.50M |
| EPS | $-0.02 |
